Nhu-y N. Nguyen

Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer.

CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer.

Journal: Molecular therapy. Oncology
Published: August 30, 2024

Targeting TAG-72 in cutaneous T cell lymphoma.

Targeting TAG-72 in cutaneous T cell lymphoma.

Journal: Heliyon
Published: March 03, 2024

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.

Journal: Bioengineering & translational medicine
Published: January 09, 2023

Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer.

Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer.

Journal: Molecular therapy oncolytics
Published: August 05, 2020

Androgens stimulate erythropoiesis through the DNA-binding activity of the androgen receptor in non-hematopoietic cells.

Androgens stimulate erythropoiesis through the DNA-binding activity of the androgen receptor in non-hematopoietic cells.

Journal: European journal of haematology
Published: March 06, 2020

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Journal: Cancer cell
Published: September 14, 2016

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

Journal: Blood
Published: May 24, 2016

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.

Journal: Science translational medicine
Published: August 26, 2015

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Journal: Cancer cell
Published: April 08, 2015

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.

Journal: Blood
Published: September 27, 2014

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.

Journal: Blood
Published: June 19, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026